Taken together, our ERα targetome revealed that the majority of ERα binding is located in distal regions of genes in the mammary gland, which is consistent with previous reports of ER binding sites in ER-positive breast cancer cells [21–23]. The gene discussed is ESR1; the disease is breast carcinoma.